Riociguat in children with pulmonary arterial hypertension: the PATENT-CHILD study

Riociguat, a soluble guanylate cyclase stimulator, is approved for treatment of adults with pulmonary arterial hypertension (PAH). The safety, tolerability, and pharmacokinetics (PK) of oral riociguat in a pediatric population with PAH was assessed in PATENT-CHILD (NCT02562235), a multicenter, singl...

Full description

Saved in:
Bibliographic Details
Main Authors: Garcia-Aguilar, Humberto (Author) , Gorenflo, Matthias (Author) , Ivy, D. Dunbar (Author) , Moledina, Shahin (Author) , Castaldi, Biagio (Author) , Ishida, Hidekazu (Author) , Cześniewicz, Paweł (Author) , Kusa, Jacek (Author) , Miera, Oliver (Author) , Pattathu, Joseph George (Author) , Weng, Ken-Pen (Author) , Ablonczy, Laszlo (Author) , Apitz, Christian (Author) , Katona, Marta (Author) , Kurosaki, Kenichi (Author) , Pulido, Tomas (Author) , Yamagishi, Hiroyuki (Author) , Yasuda, Kazushi (Author) , Cisternas, Galia (Author) , Goth, Melanie (Author) , Lippert, Susanne (Author) , Radomskyj, Anna (Author) , Saleh, Soundos (Author) , Willmann, Stefan (Author) , Wirsching, Gabriela (Author) , Bonnet, Damien (Author) , Beghetti, Maurice (Author)
Format: Article (Journal)
Language:English
Published: 01 September 2022
In: Pulmonary circulation
Year: 2022, Volume: 12, Issue: 3, Pages: 1-12
ISSN:2045-8940
DOI:10.1002/pul2.12133
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1002/pul2.12133
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/pul2.12133
Get full text
Author Notes:Humberto García Aguilar, Matthias Gorenflo, D. Dunbar Ivy, Shahin Moledina, Biagio Castaldi, Hidekazu Ishida, Paweł Cześniewicz, Jacek Kusa, Oliver Miera, Joseph Pattathu, Ken-Pen Weng, Laszlo Ablonczy, Christian Apitz, Marta Katona, Kenichi Kurosaki, Tomas Pulido, Hiroyuki Yamagishi, Kazushi Yasuda, Galia Cisternas, Melanie Goth, Susanne Lippert, Anna Radomskyj, Soundos Saleh, Stefan Willmann, Gabriela Wirsching, Damien Bonnet, Maurice Beghetti
Description
Summary:Riociguat, a soluble guanylate cyclase stimulator, is approved for treatment of adults with pulmonary arterial hypertension (PAH). The safety, tolerability, and pharmacokinetics (PK) of oral riociguat in a pediatric population with PAH was assessed in PATENT-CHILD (NCT02562235), a multicenter, single-arm, 24-week, open-label, Phase 3 study.
Item Description:Gesehen am 29.11.2022
Physical Description:Online Resource
ISSN:2045-8940
DOI:10.1002/pul2.12133